Rhythm Pharmaceuticals (RYTM) Share-based Compensation (2016 - 2026)
Rhythm Pharmaceuticals (RYTM) reported Share-based Compensation of $25.03 million for Q3 2026, up 33.0% from $18.81 million a year earlier but down 4.0% from the prior quarter.
Powered by 
Analysis
Rhythm Pharmaceuticals (RYTM) Share-based Compensation (2016 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Rhythm Pharmaceuticals' Share-based Compensation came in at $93.45 million, up 60.8% year-over-year; for FY2025, it came in at $66.82 million, up 68.4% from FY2024.
- Share-based Compensation has increased for three consecutive years, with a five-year compound annual growth rate of 30.8% (FY2020 to FY2025).
- By year, Share-based Compensation came in at $39.68 million in FY2024 (+21.9%), $32.55 million in FY2023 (+64.2%), $19.83 million in FY2022 (-4.7%) and $20.8 million in FY2021 (+19.2%).
- Five-year quarterly Share-based Compensation spans a low of $4.61 million in Q1 2022 and a high of $26.06 million in Q2 2026.
- Year over year, Share-based Compensation has now increased in each of the last 16 quarters, with growth averaging 58.9% over the last eight quarters.
- The high point for year-over-year Share-based Compensation in five years was Q4 2025 (growth of 82.5%); the low point was Q1 2022 (a decline of 11.2%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $26.06 million (Q2 2026), $23.1 million (Q1 2026) and $19.27 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 200.00 Mn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 357.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 160.00 Mn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 369.00 Mn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 128.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 234.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 362.00 Mn |
| 10 | Rhythm Pharmaceuticals | 7.86 Bn | 6.48 Bn | 79.96 Mn | 25.03 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 25.03 Mn |
| Jun 30, 2026 | 26.06 Mn |
| Mar 31, 2026 | 23.10 Mn |
| Dec 31, 2025 | 19.27 Mn |
| Sep 30, 2025 | 18.81 Mn |
| Jun 30, 2025 | 15.88 Mn |
| Mar 31, 2025 | 12.86 Mn |
| Dec 31, 2024 | 10.56 Mn |
| Sep 30, 2024 | 11.00 Mn |
| Jun 30, 2024 | 10.36 Mn |
| Mar 31, 2024 | 7.77 Mn |
| Dec 31, 2023 | 8.67 Mn |
| Sep 30, 2023 | 8.61 Mn |
| Jun 30, 2023 | 8.89 Mn |
| Mar 31, 2023 | 6.38 Mn |
| Dec 31, 2022 | 5.29 Mn |
| Sep 30, 2022 | 4.80 Mn |
| Jun 30, 2022 | 5.14 Mn |
| Mar 31, 2022 | 4.61 Mn |
| Dec 31, 2021 | 4.68 Mn |
API Access
Rhythm Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RYTM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "RYTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RYTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();